Stay updated on ARISEII Clinical Trial
Sign up to get notified when there's something new on the ARISEII Clinical Trial page.

Latest updates to the ARISEII Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedAn NIH-wide notice about updated terminology appears above the ClinicalTrials.gov page, while the study content remains inaccessible behind a 403 error.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision label updates from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1. The page continues to display a 403 error rather than the study record.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of displaying the study details. The site chrome (header and footer) remains visible, but access to the study content is blocked.SummaryDifference21%

- Check55 days agoChange DetectedA new PubMed citation for ARISE II, Diving MCA and First-Pass Effect: A Subgroup Analysis From the ARISE II Study, was added to the Publications section. This shows continued academic reporting related to the study.SummaryDifference0.0%

Stay in the know with updates to ARISEII Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARISEII Clinical Trial page.